Summary
The present study performed on a total of 567 cases of human female breast cancer compares the results of the biochemical assay (dextran-coated charcoal assay=DCC) for oestrogen receptor (ER) with those of several morphological methods developed for the detection of the ER or for the prediction of prognosis by use of other systems (FSA= fluorescent ligand binding assay, ER-ICA=monoclonal antibody assay for ER, LRA=lectin receptor assay using peanut agglutinin, and Barr body estimation). Whereas no correlation at all was observed among the results of the DCC and those of the FSA and Barr body estimation, the ER-ICA and the LRA showed an unanimous tendency towards higher values of ER with increasing intensity of the staining product. The results of the ER-ICA may be expressed by an immuno-reactive score (IRS) calculated from the staining intensity (SI) and the percentage of positive cells (PP). The morphological methods are evaluated with special regard to their correlation with the DCC, their theoretical basis, and their practical application. In summary, the ER-ICA appears to be the sole method directly visualizing the ER protein and - in contrast to the DCC - is therefore completely independent of the content of endogenous or exogenous oestrogens in the tumor tissue. The LRA provides valuable additional information concerning tumour differentiation
Similar content being viewed by others
References
Alanko A (1985) Variaton of estrogen and progesterone receptor status in breast cancer. Ann Clin Res 17:10–14
Barrows GH, Stroupe SB, Riehm JD (1980) Nuclear uptake of a 17β-estradiol-fluorescein derivative as a marker of estrogen dependence. Am J Clin Pathol 73:330–339
Beck T, Heubner A, Pollow K (1985) Immunhistochemischer Östrogenrezeptornachweis mit monoklonalen Antikörpern in Mammakarzinomen. Quantifizierende Ergebnisse in Korrelation zur biochemischen Rezeptorbestimmung im Zytosol. 16. Herbsttagg Dtsch Ges Pathol, Mainz
Berns EMJJ, Mulder E, Rommerts FFG, Blankenstein RA, de Graaf E, van der Molen HJ (1984) Fluorescent ligands, used in histochemistry, do not discriminate between estrogen receptor-positive and receptor-negative human tumor cell lines. Breast Cancer Res Treatm 4:195–204
Bishun NP, Smethurst M, Williams DC (1979) The relationship between Barr bodies and cytoplasmic oestradiol receptors in human breast cancer. Clin Oncol 5:147–151
Bishun NP, Smethurst M, Williams DC (1981) Age, sex chromatin, and estrogen receptor status in women with breast cancer. Cancer Genet Cytogenet 4:353–355
Bloom HJG, Richardson WW (1957) Histological grading and prognosis in breast cancer. Br J Cancer 11:359–377
Bojar H, Ertl D (1984) Comparison of immunocytochemical estrogen receptor assay (ER-ICA), biochemical estrogen receptor enzyme immunoassay (ER-EIA), and radioligand binding assay (ER-RBA) in human breast cancer. Monte-Carlo Symposium on estrogen receptor determination with monoclonal antibodies
Bosman FT, Blankenstein M, Daxenbichler G, Falkmer S, Heitz PhU, Kracht J (1985) What's new in endocrine factors of tumor growth? Pathol Res Practice 180:81–92
Caffier H, Brandau H (1978) Beeinflussung des Östrogen- und Progesteronrezeptornachweises in Mammakarzinomgeweben durch endogene Hormone. Arch Gynäkol 225:255–265
Carlström K (1984) Influence of intratumoral estradiol biosynthesis on estrogen receptors. Rec Res Cancer Res 91:145–149
Chabon AA, Goldberg JD, Venet L (1982) Carcinoma of the breast: interrelationships among histopathologic features, estrogen receptor activity, and age of the patient. Hum Pathol 14:368–372
Chamness GC, Mercer WD, McGuire WL (1980) Are histochemical methods for estrogen receptor valid? J Histochem Cytochem 8:792–798
Charpin C, Jacquemier J, Martin PM, King W, Lavaut MN, Poureau-Schneider N, Toga M (1984) Immunocytochemical detection of estrogen receptor (monoclonal anti-ER, PAP) in 103 malignan breast tumors: morphological data and correlations with biochemical assay. Monte-Carlo Symposium on estrogen recetor determination with monoclonal antibodies
Coombes RC, McClelland RA, Berger U, Miller L, Jensen E, Neville AM (1984) Use of an enzyme linked immunocytochemical assay (ER-ICA) utilising a monoclonal antibody to estrogen receptor (ER) in predicting response to endocrine therapy in advanced breast cancer patients. Monte-Carlo Symposium on estrogen receptor determination with monoclonal antibodies
Danguy A, Leclercq G, Pattyn G, Pasteels JL, Heuson JC (1981) La mise en évidence cytochimique des récepteurs stéroidiens: un nouvel outil dans le domaine de la cancérologie mammaire. Rev Méd Brux 2:477–481
Daxenbichler G (1982) Histochemischer Nachweis hormonsensitiver Zellen. In: Steroidhormonrezeptoren im Karzinomgewebe. Jonat W, Maass H (Hrsg). Bücherei des Frauenarztes, Stuttgart, Enke, Bd 12, S181–197
Daxenbichler G, Weiss P, Piegger E (1982) Critical evaluation of histochemical “receptor” assays. In: Proc XIth Internatl Congr Clin Chemistry, Berlin, de Gruyter, pp 459–465
Eiermann W, Klug G, Untch M, Schenck U, Hepp H (1985) Comparative investigations for the detection of estrogen receptor protein in breast cancer tissue with mABs. Internatl Symposium on monoclonal antibodies in clinical oncology. November 8/9, 1985, Homburg/ Saar
E.O.R.T.C. breast cancer cooperative group (1980) Revision of the standards for the assessment of hormone receptors in breast cancer. Eur J Cancer 16:1513–1515
Feherty P, Farrer-Brown G, Kellie AE (1971) Oestradiol receptors in carcinoma and benign disease of the breast: an in vitro assay. Br J Cancer 25:697–710
Fetisoff F, Lansac J, Arbeille-Brassart B (1980) Mise en évidence des récepteurs de l'oestradiol et de la progestérone sur préparations histologiques. Ann Anat Pathol (Paris) 25:201–206
Folca PJ, Glascock RF, Irvine WT (1961) Studies with tritium--labelled hexoestrol in advanced breast cancer. Lancet 2:796–798
Frank K, Heine M, Remmele W (1980) Fluoreszenzmikroskopische Bestimmung der Östrogen-Rezeptor-Aktivität von Mammakarzinomen. Pathologe 2:51–55
Furnival CM, Chong KC, Watson LR, Visona A (1983) Fluorescent cytochemical oestrogen receptor assay: is it valid in breast cancer? Br J Surg 70:457–459
Gille J (1985) Personal communication
Greene GL, Jensen EV (1982) Monoclonal antibodies as probes for estrogen receptor detection and characterization. J Steroid Biochem 16:353–359
Greene GL, King WJ, Press MF, Miller LS, Nolan C, DeSombre ER, Jensen EV (1984) The use of monoclonal antibodies to develop immunocytochemical assays for estrogen receptor in reproductive cancers. Monte-Carlo Symposium on estrogen receptor determination with monoclonal antibodies
Greene GL, Nolan C, Engler JP, Jensen EV (1980) Monoclonal antibodies to human estrogen receptor. Proc Natl Acad Sci 77:5115–5119
Heubner A (1985) Diskussionsbemerkung zu Beck T et al. 16. Herbsttagg Dtsch Ges Path, Mainz, 12.10.1985
Heubner A, Belovsky O, Pollow K, Grill HJ, Manz B (1985) A new procedure for the purification of human uterine progesteron receptor: combination of Org2058 affinity resin with HPLC-anion exchange chromatography. In: Jonat W, Kaufmann M, Kubli F, Maass H (Hrsg) Prätherapeutische Tumortestung. Zuckschwerdt, München Bern Wien, S 50–68
Hienz HA (1959) Die zellkernmorphologische Geschlechtserkennung in Theorie und Praxis, Heidelberg, Hüthig
Hienz HA (1965) Die zellkernmorphologische Geschlechtserkennung an Tumoren. Med Welt 1965:2803–2810
Högel B, Jawny J, Eiermann W (1982) Fluoreszenzmikroskopischer Nachweis von Östrogen-und Gestagenrezeptoren im Mammakarzinom. Tumordiagnostik 3:6–8
Horie A, Nomura Y, Stemmerman GN, Catts A, Fukunaga FH, Shigematsu T, Hirohata T, Nomura AMY (1984) Histopathological features and their association with steroid receptors in women with breast cancer in Fukuoka, Japan. Acta Pathol Jpn 34:229–239
Jakesz R, Kolb R, Reiner G, Chaput B, Schemper M (1979) Unterschiedliche Östrogenrezeptorgehalte in Mammakarzinomen. Helv Chir Acta 45:763–767
Jensen EV, Jacobson HI (1960a) Fate of steroid estrogens in target tissues. In: Pincus G, Vollmer EP (eds) Biological activities of steroids in relation to cancer. Academic, New York, p 161
Jensen EV, Jacobson HI (1960b) Basic guide to the mechanism of estrogen action. Rec Progr Horm Res 18:387–414
Jonat W, Stegner HE (1984) Immunocytochemical detection and measurement of estrogen receptors in stored breast cancer tissue samples. Monte-Carlo Symposium on estrogen receptor determination with monoclonal antibodies
Jonat W, Stegner H-E, Maass H (1985) Immunhistochemische Bestimmung von Östrogenrezeptoren in Mammakarzinomgeweben mittels monoclonaler Antikörper. Erste klinische Ergebnisse. Geburtsh Frauenheilk 45:473–476
King WJ, Greene GL (1984) Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells. Nature 307:745–747
Klein P-J (1985) Personal communication
Klein PJ, Newman RA, Müller P, Uhlenbruck G, Citoler P, Schaefer HE, Lennartz KJ, Fischer R (1979) The presence and significance of the Thomsen-Friedenreich antigen in mammary gland. II. Its topochemistry in normal, hyperplastic, and carcinoma tissue of the breast. J Cancer Res Clin Oncol 93:205–214
Klein PJ, Newman RA, Müller P, Uhlenbruck G, Schaefer HE, Lennartz KJ, Fischer R (1978) Histochemical methods for the demonstration of Thomsen-Friedenreich antigen in cell suspension and tissue sections. Klin Wochenschr 56:761–765
Klein PJ, Vierbuchen M, Fischer J, Schulz K-D, Farrar G, Uhlenbruck G (1983) The significance of lectin receptors for the evaluation of hormone dependence in breast cancer. J Steroid Biochem 19:839–844
Kolb R, Reiner G, Jakesz R, Schemper M (1979) Topische Unterschiede im Östrogenreceptorgehalt primärer Mammacarinome. Chir Forum Exp Klin Forsch 1979:179–182
Kute TE, Linville C, Barrows G (1983) Cytocfluorometric analysis for estrogen receptors using fluorescent estrogen probes. Cytometry 4:132–140
Leclercq G, Bojar H, Goussard J, Pichon MF, Nicholson RA, Piffanelli A, Poussette A, Thorpe S, Lonsdorfer M (1984) Results of a multicenter study on ER-EIA Monoclonal in Europe. Monte-Carlo symposium on estrogen receptor determination with monoclonal antibodies
Lee SH (1978) Cytochemical study of estrogen receptor in human mammary cancer. Am J clin Pathol 70:197–203
Lee SH (1980) Estrogen and progesterone receptors in breast cancer - a new approach to measure. Connect Med 44:622–625
Lüttges J, Zwiorek L (1985) Östrogenrezeptorstatus beim Mammakarzinom: Vergleichende immunhistologische und biochemische Untersuchungen. 16. Herbsttagg Dtsch Ges Pathol, Mainz
Manfreda D, Aigner H, Daxenbichler G, Pflanzl G, Redtenbacher M (1985) Vergleich zwischen biochemischer und histochemischer Hormonrezeptorenbestimmung bei Mammakarzinomen. Onkologie 8:111–112
Manz B, Böcker W, Grill H-J, Belovsky O, Pollow K (1983) Cytochemical analysis of human breast cancer with fluorescent sex-steroid conjugates: end of a legend? J Steroid Biochem 19, Suppl 1983, p 348
Martin JR, Sheridan PJ (1982) Towards a new model for the mechanism of acction of steroids. J Steroid Biochem 16:215–229
Martin PM, Rolland PH, Jacquemier J, Rolland AM, Toga M (1979) Multiple steroid receptors in human breast cancer. III. Relationships between steroid receptors and the state of differentiation and the activity of carcinomas throughout the pathologic features. Cancer Chemother Pharmacol 2:115–120
Maynard PV, Davies CJ, Blamey RW, Elston CW, Johnson J, Griffiths K (1978) Relationship between oestrogen-receptor content and histological grade in human primary breast tumours. Br J Cancer 38:745–748
McCarty KS Jr, Reintgen DS, Seigler HF, McCarty KS Sr (1981) Cytochemistry of sex steroid areceptors: a critique. Breast Cancer Res Treatm 1:315–325
McCarty RS, Miller L, Cox EB, Flowers JL, Budwit DA, Szabo E, Snowhite JC, Konrath J, McCarty KS (1984) Clinical and histological correlation of estrogen receptor distribution as determined by immunocytochemistry using monoclonal antibody. Monte-Carlo Symposium on estrogen receptor determination with monoclonal antibodies
Meijer CJLM, van Marle J, Persijn JP, Van Niewenhuizen W, Baak JLA, Boon ME, Lindeman J (1982) Estrogen receptors in human breast cancer. II. Correlation between the histochemical method and biochemical assay. Virchows Arch [Cell Pathol] 40:27–37
Nadji M (1985) Immunocytochemistry in mammary carcinoma. In: Jonat W, Kaufmann M, Kubli F, Maass H (Hrsg) Prätherapeutische Tumortestung. München Bern Wien, Zuckschwerdt, S 5–9
Nenci I (1981) Estrogen receptor cytochemistry in human breast cancer: status and prospects. Cancer 48:2674–2686
Nenci I, Marchetti E, Marzola A, Fabris G (1981) Affinity cytochemistry visualizes specific estrogen binding sites on the plasma membrane of breast cancer cells. J Steroid Biochem 14:1139–1146
Nishimura R, Misumi A, Kimura M, Tokunaga T, Akagi M (1982) Relationship between the content of estrogen and progesterone receptors and the pathological characteristics in human breast cancer. Jpn J Surg 12:191–197
O'Connell M, McDonnell L, Duffy MJ (1982) Studies on nuclear estradiol receptors in human mammary carcinoma. Clin Chemica Acta 119:285–289
O'Connell MD, Said JW (1983) Estrogen receptors in carcinoma of the breast. A comparison of the dextran-coated charcoal, immunofluorescent, and immunoperoxidase techniques. Am J Clin Pathol 80:1–5
Ozzello L, DeRosa C, Konrath JG, Yeager JL (1984) Immunocytochemical detection of estrogen receptor in breast cancer using Abbott ER-ICA kit. Monte-Carlo Symposium on estrogen recetor determination with monoclonal antibodies
Parl FF, Wagner RK (1980) The histopathological evaluation of human breast cancers in correlation with estrogen receptor values. Cancer 46:362–367
Penney GC, Hawkins RA (1982) Histochemical detection of oestrogen receptors: a progress report. Br J Cancer 45:237–246
Pertschuk LP, Eisenberg KB, Carter AC, Feldman JG (1985) Heterogeneity of estrogen binding sites in breast cancer: morphologic demonstration and relationship to endocrine response. Breast Cancer Res Treatm 5:137–147
Pertschuk P, Gaetjens E, Eisenberg KB (1981) Steroid hormone receptor proteins. Histochemical markers of potential hormone-dependence. Meth Achiev Exp Pathol 10:162–189
Pertschuk LP, Tobin EH, Brigati DJ, Gaetjens E (1980) Morphologic assay of steroid hormone receptors in human neoplasia. Pathology Annual, pt 2, 143–180
Pertschuk LP, Tobin EH, Carter AC, Eisenberg KB, Leo VC, Gaetjens E, Bloom ND (1982) Immunohistologic and histochemical methods for detection of steroid binding in breast cancer. Breast Cancer Res Treatm 1:297–314
Pickartz H (1985) Rundtischgespräch: Oestrogen- und Progesteronrezeptoren in der heutigen Diagnostik des invasiven Mammakarzinoms. 69. Tagg Dtsch Ges Pathol, Köln 1985
Poulsen HS, Ozzello L, Andersen J (1982) Oestrogen receptors in human breast cancer. Problems of correlation with histopathological features. Virchows Arch [Pathol Anat] 397:103–108
Poulsen HS, Ozzello L, King WJ, Greene GL (1985) The use of monoclonal antibodies to estrogen receptors (ER) for immunoperoxidase detection of ER in paraffin sections of human breast cancer tissue. J Histochem Cytochem 33:87–92
Raam S, Nemeth E, Tamura H, O'Briain DS, Cohen JL (1982) Immunohistochemical localization of estrogen receptors in human mammary carcinoma using antibodies to the receptor protein. Eur J Cancer 18:1–12
Rajeswari S, Ghosh SN, Shah PN, Borah VJ (1977) Barr body frequency in the human breast cancer tissue. A prospective study on its prognostic value and its correlation with specific oestradiol receptors. Eur J Cancer 13:99–102
Reiner G, Bieglmayer Ch, Jakesz R, Kees A, Kolb R, Spona J (1981) Steroidrezeptoren im Mammakarzinom in Beziehung zum basalen Serumhormonspeigel bei postmenopausalen Patientinnen. Wien Klin Wochenschr 93:339–342
Remmele W (1981) de, Diskussionsbemerkung. In: Bässler R, Prechtel K Pathologie des Mammakarzinoms.
Remmele W, Heicke B, Heine M, Frank K, Keogh HJ, Schmitt A (1982) Bestimmung der Steroidrezeptoren im Mammakarzinom. Methodik und Empfehlungen für die Praxis. Dtsch Ärztebl 79:35–40
Rosen PP, Savino A, Menendez-Botet C, Urban JA, Mike V, Schwartz MK, Melamed MR (1977) Barr body distribution and estrogen receptor protein in mammary carcinoma. Ann Clin Lab Sci 7:491–499
Shimada A, Kimura S, Abe K, Nagasaki K, Adachi I, Yamaguchi K, Suzuki M, Nakajima T, Miller LS (1985) Immunocytochemical staining of estrogen receptor in paraffin sections of human breast cancer by use of monoclonal antibody; comparison with that in frozen sections. Proc Natl Acad Sci USA 82:4803–4807
Silfverswärd C, Skoog L, Humla S, Gustafsson SA, Nordenskjöld B (1980) Intratumoral variation of cytoplasmic and nuclear estrogen receptor concentrations in human mammary carcinoma. Eur J Cancer 16:59–65
Smethurst M, Bishun NP, Fernandez D, Allen J, Burn JI, Alaghband-Zadeh J, Williams DC (1981) Steroid hormone receptors and sex chromatin frequency in breast cancer. J Endocrinol Invest 4:455–457
Stegner H-E, Jonat W, Maass H (1985) Immunohistochemischer Nachweis nukleärer Östrogenrezeptoren mit monoclonalen Antikörpern in verschiedenen Typen des Mammakarzinoms. Pathologe (in press)
Underwood JCE (1983) Oestrogen receptors in human breast cancer: review of histopathological correlations and critique of histochemical methods. Diagnostic Histopathol 6:1–22
Underwood JCE, Sher E, Reed M, Eisman MA, Martin TJ (1982) Biochemical assessment of histochemical methods for oestrogen receptor localisation. J Clin Pathol 35:401–406
Van Bogaert L-L (1985) Present status of estrogen-receptor immuno-histochemistry. Acta Histochem 76:29–35
Van Marle J, Lindeman J, Ariens ATh, Labruyère W, van Weeren-Kramer J (1982) Estrogen receptors in human breast cancer. I. Specifity of the histochemical localization of estrogen receptors using an estrogen-albumin FITC complex. Virchows Arch [Cell Pathol] 40:17–25
Van Netten JP, Algard Th, Coy P, Carlyle SJ, Bridgen ML, Thornton KR, Peter S, Fraser T, To MP (1985) Heterogenous estrogen receptor levels detected bia multiple microsamples from individual breast cancers. Cancer 56:2019–2024
Vierbuchen M, Klein PJ, Rösel S (1983) Vorkommen, Verteilung und Hormonabhängigkeit von Lektinbindungsstellen in N-Nitrosomethylharnstoff-induzierten Mammakarzinomen der Ratte. In: Koenig UD (Hrsg) Immunologie und Tumormarker beim Mammakarzinom. Ferdinand Encke, Stuttgart, S 78–88
Welshons WV, Lieberman ME, Gorski J (1981) Nuclear localization of unoccupied oestrogen receptors. Nature 307:747–749
Author information
Authors and Affiliations
Additional information
Dedicated to Professor Karl Lennert, Kiel, on the occasion of his 65th birthday
Supported in part by the German Cancer Fund (Deutsche Krebshilfe)
Rights and permissions
About this article
Cite this article
Remmele, W., Hildebrand, U., Hienz, H.A. et al. Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancer. Vichows Archiv A Pathol Anat 409, 127–147 (1986). https://doi.org/10.1007/BF00708323
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00708323